Psychosocial Adjustment of Patients and Their Partners Following Breast Cancer Diagnosis

NCT01392066 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1584

Last updated 2014-04-23

No results posted yet for this study

Summary

The purpose of this study is to describe psychosocial adjustment in patients with breast cancer and their cohabiting partners/spouses throughout the cancer trajectory, to study mutual influences of the partner on the patient and vice versa, and to identify risk and protective factors that influence the adjustment process in both patients and partners. The overall aim is to generate knowledge that helps enables us to integrate the partners' needs, problems and resources in treatment and rehabilitation of breast cancer patients.

Conditions

Interventions

BEHAVIORAL

questionnaire

Both the patient and the partner/spouse fill out a questionnaire that assesses their psychosocial adjustment. Time for completion is ca. 30 minutes. The questionnaire is administered at baseline and 5- and 12-months follow up.

Sponsors & Collaborators

  • Danish Cancer Society

    collaborator OTHER
  • University of Groningen

    collaborator OTHER
  • Rigshospitalet, Denmark

    collaborator OTHER
  • Herlev Hospital

    collaborator OTHER
  • University of Southern Denmark

    lead OTHER

Principal Investigators

  • Dorte Gilså Hansen, MD, PhD · Research Unit of General Practice, Institute of Public Health, University of Southern Denmark

  • Christoffer Johansen, MD, PhD, DMSc · Institute of Cancer Epidemiology, Danish Cancer Society

  • Mariet Hagedoorn, MSc, PhD · University Medical Center Groningen

  • Nina Rottmann, MSc · Research Unit of General Practice, Institute of Public Health, University of Southern Denmark

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2013-07-31
Completion
2013-10-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01392066 on ClinicalTrials.gov